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IV – Valorisation 
“The important thing is not to stop questioning. Curiosity has its own reason for 
existing. One cannot help but be in awe when he contemplates the mysteries of 
eternity, of life, of the marvelous structure of reality. It is enough if one tries merely 
to comprehend a little of this mystery every day.” 
Albert Einstein 
Knowledge utilisation is the process of making knowledge valuable by making it 
suitable for social or economic use and for translation into competitive products, 
services, processes and new commercial activities (definition based on the National 
Valorisation Committee 2011). Over the past decades, such practical applicability of 
research has increasingly become a prerequisite for obtaining government funding in 
the Netherlands and elsewhere. Yet, when asked why they spend their unpaid 
evenings and weekends performing experiments, analysing data and writing papers, 
few fundamental researchers will reply: “Because I am trying to save the world.” or 
“Because my research will give a real boost to the Dutch economy.” I, for one, might 
reply: “Because cells produce extracellular vesicles, and I really want to understand 
why.” 
I believe that the intrinsic curiosity that drives many fundamental 
researchers is what allowed mankind to develop into the modern society that we are. 
An example of a purely curiosity-driven finding is the discovery of the 
hyperthermophilic bacterium Thermus aquaticus that lives in hot springs in the 
Yellowstone National Park [1]. While this beautiful finding showed that life is 
possible under circumstances (i.e. at temperatures) that were previously thought 
incompatible with life, no one at the time would have anticipated that the 
thermoresistant DNA polymerase of Thermus aquaticus would form the basis for one 
of the most important biotechnological inventions of the late 20
th
 century, the 
polymerase chain reaction (PCR). PCR is now one of the most used laboratory 
techniques in molecular biology research and has substantially improved and 
accelerated the diagnostic process for several diseases, including viral and bacterial 
infections. 
Obviously, it is unlikely that the research presented in this dissertation, or 
most other fundamental studies, will have a similar impact on science, healthcare 
and society as the discovery of Thermus aquaticus. However, to quote Thomas 
Levenson of the Massachusetts Institute of Technology, “Science is a set of ways of 
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thinking and acting through which, sometimes, results emerge. Failure, “wasted” 
time, is intrinsic to that process. It’s impossible to do science without a tolerance for 
uncertainty over the years or decades it can take to reveal what many discoveries 
actually mean.” [2] Moreover, “Science as a body of knowledge is powerful, valuable, 
essential to human well-being. Science as a human process is wasteful, necessarily — 
and even more, usefully — so.” [2] The major and, in my opinion, most relevant 
societal gain of the studies in this dissertation is that they make a contribution to the 
body of human knowledge (however little it may be). 
Societal and economic relevance 
On a less philosophical and more practical note, this thesis describes a number of 
fundamental studies investigating extracellular vesicles (EVs) as a novel mechanistic 
link between exposure to respiratory toxicants such as cigarette smoke and the 
development of respiratory exposure-associated chronic diseases. Despite extensive 
efforts to control smoking prevalence, smoking currently causes 10% of all deaths 
worldwide [3, 4]. It is projected to continue making an important contribution to the 
public health burden in the coming decades, in terms of productivity losses, health 
expenditures and mortality [3, 5]. Additionally, respiratory exposure to air 
pollutants, especially in urbanised areas, is also an important public health concern 
[6]. Smoking and exposure to high levels of air pollution are both associated with 
increased risks for developing cardiovascular disease, chronic lung disease and 
cancer [4, 6]. Improved understanding of how respiratory exposures cause these 
diseases is highly relevant, as it forms the first step for developing novel preventive 
and therapeutic strategies. In this thesis, we have found that cultured lung cells 
exposed to cigarette smoke release procoagulant EVs which may contribute to the 
increased cardiovascular risk in smokers, and which may even be involved in lung 
pathogenesis. While we did not find any significant changes in circulating 
procoagulant EVs between young healthy smokers and non-smokers, only a sub-
group of smokers may respond to respiratory exposures with elevated concentrations 
of circulating procoagulant EVs. In that case, these EVs could be used as a non-
invasive biomarker of risk to identify those individuals that are susceptible to 
developing chronic disease in response to respiratory toxicants. We have also shown 
that the clinically tested antioxidant NAC and its active metabolic product 
glutathione can prevent the release of procoagulant EVs in cells exposed to smoke. 
Although these are very early stage in vitro findings, they provide a rationale for 
testing the efficacy of NAC to prevent cardiovascular adverse events in individuals 
with a history of exposure to respiratory toxicants, such as COPD patients. 
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Target groups 
At the current stage, the findings of this research project are mainly relevant to the 
scientific community, which may use them as the basis for additional fundamental 
and clinical studies. As suggested in the general discussion of this dissertation 
(chapter 9) and in the previous section, future research could focus on determining 
whether circulating EVs can serve as biomarkers of exposure to respiratory toxicants 
and/or for the risk of developing disease. For this purpose, sensitive, specific and fast 
methods for the detection of procoagulant EVs in plasma should be developed. 
Moreover, it could be tested whether NAC can benefit additional target groups 
besides the subgroup of COPD patients who currently receive NAC for its mucolytic 
activity. These intermediate steps are required before the findings described in this 
thesis can be used by the pharmaceutical industry as a basis to develop novel EV 
based screening tests or before NAC may be implemented in additional target 
groups in the clinic. 
Products and innovation 
An important aspect of the work presented in this dissertation was the development 
of two techniques; one for reliable detection of EVs and EV subtypes in cell culture 
media, and one for isolation of EVs from cell culture media. While we are not the 
first ones to use these techniques, and no commercial benefit arises from publishing 
our protocols, making the protocols publicly available is a valuable contribution to 
the scientific community. While EVs attract increasing attention and interest from 
the biomedical research community, only relatively few large and specialised 
research groups have the expertise, funding and equipment to perform EV isolation 
and characterisation at the highest quality level. Unfortunately, applying these 
highest quality techniques as a standard for daily use in smaller or less specialised 
laboratories seems almost impossible. To prevent a large number of low quality 
studies being performed with suboptimal EV isolation techniques, such as 
commercial precipitation kits, techniques need to be developed that are cost-
effective, easy and fast to perform. These techniques should also be reliable in terms 
of specificity for EV detection and in terms of yield and purity for EV isolation. We 
think that these prerequisites are met by the bead-based flow cytometry that we 
describe for EV detection and the ultrafiltration with size exclusion chromatography 
that we describe for EV isolation. Therefore, the publication of these protocols 
should be a valuable contribution to the EV research community. 
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Personal development of the candidate and 
contributions to the scientific community 
This PhD project has been the result of a proposal written by the PhD candidate. 
During the proposal writing, as well as during the PhD project itself, the candidate 
learned a lot about planning, performing and writing about scientific research. 
Furthermore, the candidate has attended several specialised courses and gained 
teaching experience as a tutor for Bachelor and Master students. The research was 
performed with a supervision team from two departments at Maastricht University, 
Medical Microbiology and Respiratory Medicine. Moreover, a lot of the work was 
done in close collaboration with researchers from the departments of Toxicology and 
Pharmacology, Toxicogenomics, Human Biology, and Biochemistry. Thereby, this 
project has brought together experts from different fields of biomedical research and 
has resulted in an intensive exchange of knowledge and in shared use of specialised 
equipment. This group effort was largely initiated by the PhD candidate and has 
resulted in two original research papers in international peer-reviewed journals with 
the PhD candidate as first author, as well as four publications with the PhD 
candidate as second author. Two review articles have also been published with the 
PhD candidate as first author, providing other researchers with an overview of the 
candidate’s field of expertise. Moreover, several additional manuscripts are currently 
submitted or in preparation for publication, in order to make the findings 
originating from this PhD project broadly available to the scientific community. 
Parts of the work presented in this thesis have also been presented as posters and 
oral presentations at several conferences, including the annual meetings of the 
International Society for Extracellular Vesicles and of the European Respiratory 
Society. 
Conclusion 
The major value of the work presented in this dissertation is its contribution to the 
scientific body of knowledge. We have initiated novel collaborations between 
researchers from different departments and different fields of expertise. Moreover, 
we have published protocols that may be of value to the EV research community and 
have provided evidence that respiratory exposures induce the release of 
procoagulant EVs, which may contribute to chronic disease risk. These findings may 
form the basis for additional fundamental and clinical research and may eventually 
lead to the development of novel screening tests and/or strategies for disease 
prevention and management.  
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